8-K: SelectQuote Reports Strong Q3 2025 Results, Driven by Senior Segment Performance

SelectQuote, Inc. announced its third quarter fiscal year 2025 results, highlighting revenue growth and strong performance in its Senior segment.

Summary

• SelectQuote, Inc. reported its Q3 fiscal year 2025 results on May 12, 2025.
• The company's consolidated revenue for the quarter was $408.2 million, compared to $376.4 million in the same period last year.
• Net income for the quarter was $26.0 million, a significant increase from $8.6 million in Q3 2024.
• Adjusted EBITDA for the quarter was $37.7 million, compared to $46.6 million in the prior year.
• The company's fiscal year 2025 revenue is expected to be in the range of $1.500 billion to $1.575 billion.
• Net income (loss) for fiscal year 2025 is projected to be between $(1) million and $28 million.
• Adjusted EBITDA for fiscal year 2025 is expected to be in the range of $115 million to $140 million.
• The Senior segment reported revenue of $169.4 million and Adjusted EBITDA of $45.7 million.
• Healthcare Services revenue was $189.6 million with Adjusted EBITDA of $6.4 million, with 105,523 SelectRx members.
• The Life segment reported revenue of $45.8 million and Adjusted EBITDA of $6.4 million.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While revenue and net income increased, Adjusted EBITDA decreased, and there were declines in the Senior segment. The company is maintaining its guidance, but there are mixed signals in the results.

Positives

• Revenue increased by 8% year-over-year to $408.2 million.
• Net income significantly improved to $26.0 million from $8.6 million in the prior year.
• SelectRx membership grew by 41% year-over-year.
• The combined Senior and Healthcare Services revenue to CAC multiple is a healthy 5.8X.
• The company saw a 15% increase in year-over-year policy close rates in the Senior segment.
• Healthcare Services achieved positive Adjusted EBITDA for the eighth consecutive quarter.
• The Life segment saw Adjusted EBITDA increase by 103% to $6.4 million.

Negatives

• Adjusted EBITDA decreased to $37.7 million from $46.6 million in the same quarter last year.
• Senior segment revenue decreased by 17% to $169.4 million.
• Senior segment Adjusted EBITDA decreased by 26% to $45.7 million.
• Medicare Advantage approved policies decreased by 10% to 168,001.
• Lifetime Value of Commissions per Approved Medicare Advantage policy decreased by 8% to $915.

Risks

• The company relies on a limited number of insurance carrier partners, and termination of these relationships could adversely affect results.
• Changes in health insurance laws and regulations could impact the company's business.
• Competition from other brokers and insurance carriers could affect market share and profitability.
• Failure to attract and retain qualified personnel could hinder growth.
• Cybersecurity breaches could compromise consumer information and disrupt operations.
• The company's existing and future indebtedness could impact financial flexibility.
• The company's new SelectRx facility in Olathe, Kansas is expected to cause a near-term drag in fiscal 4Q25.

Future Outlook

SelectQuote expects fiscal year 2025 revenue to be in the range of $1.500 billion to $1.575 billion, net income (loss) to be between $(1) million and $28 million, and Adjusted EBITDA to be in the range of $115 million to $140 million.

Management Comments

• SelectQuote Chief Executive Officer, Tim Danker, remarked, 'We are very proud of the service and value we delivered to Americas seniors over this past years highly unique Medicare Advantage season.'
• Tim Danker stated that SelectQuote's agent-led model and technology-enabled information advantage made their platform more valuable than ever.
• Tim Danker noted that strong execution in the Senior business, paired with continued performance in Healthcare Services and the Life division, contributed to successful consolidated results.

Industry Context

SelectQuote operates in the competitive health insurance brokerage industry, facing competition from other brokers, online platforms, and insurance carriers selling directly to consumers; the company's performance is influenced by changes in the health insurance market, regulations, and consumer preferences.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without specific competitor data for Q3 2025.
• However, companies like eHealth, Inc. and GoHealth are comparable in the online health insurance brokerage space.
• SelectQuote's revenue growth of 8% should be compared to the growth rates of these competitors to assess relative performance.
• Similarly, Adjusted EBITDA margins should be benchmarked against industry averages and competitor results.
• The revenue to CAC multiple of 5.8x is a key indicator of marketing efficiency and should be compared to industry benchmarks to determine if SelectQuote is acquiring customers cost-effectively.

Stakeholder Impact

• Shareholders will be impacted by the company's financial performance and future outlook.
• Employees are affected by the company's growth and operational changes.
• Customers benefit from the company's services in insurance, pharmacy, and virtual care.
• Insurance carrier partners are impacted by the company's sales and policy distribution.
• Creditors are affected by the company's debt levels and ability to meet financial obligations.

Next Steps

• The company will continue to focus on growing its SelectRx membership.
• SelectQuote will ramp up operations at its new SelectRx facility in Olathe, Kansas throughout calendar year 2025.
• The company will work to improve efficiency and profitability in its Senior segment.
• SelectQuote will monitor and adapt to changes in the health insurance market and regulatory environment.

Key Dates

Keywords

SelectQuote, Financial Results, Q3 2025, Medicare Advantage, Healthcare Services, Insurance, Adjusted EBITDA, Revenue, SelectRx, Senior Segment